1
|
Xi P, Cao W, Li L, Shi W, Li F, Xu H, Xu X, Ke Y, Zhang J. Identification of related impurities in an oral pharmaceutical formulation of tebipenem pivoxil using ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2021; 35:e9129. [PMID: 34097785 DOI: 10.1002/rcm.9129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Revised: 04/29/2021] [Accepted: 05/21/2021] [Indexed: 06/12/2023]
Abstract
RATIONALE Tebipenem pivoxil (TBPM-PI) has been developed as the first oral carbapenem drug in the world to treat otolaryngological and respiratory infections in pediatric patients. Due to its structural properties and external factors, some related impurities, which may cause side effects in patients, might be formed during the synthesis and storage of TBPM-PI. It was vital to rapidly separate and identify the related impurities to guarantee the safe use of TBPM-PI. METHODS A method using ultra-high-performance liquid chromatography (UHPLC) coupled with quadrupole time-of-flight tandem mass spectrometry (QTOF-MS/MS) was developed to separate and detect TBPM-PI and related impurities in an oral pharmaceutical formulation. LC/MS and MS/MS spectra of these compounds in the formulation were acquired to confirm their elemental compositions and propose their structures based on LC/MS data and fragmentation pathways of available reference substances. RESULTS LC/MS parameters and MS/MS fragmentation pathways of reference substances of TBPM-PI and related impurities were summarized in detail. Based on this, a total of 23 related impurities were found and characterized in the oral pharmaceutical formulation. Eight of these were verified by comparison with reference substances and the structures of the other 15 were proposed for the first time. In addition, four of these compounds were produced by the reaction of excipients and pre-existing related impurities. CONCLUSIONS A UHPLC/QTOF-MS method was established and used for the separation and identification of 23 related impurities in a TBPM-PI oral pharmaceutical formulation. Moreover, it was proved that new related impurities could be produced by the reaction of excipients in the pharmaceutical formulation and related impurities in the corresponding active pharmaceutical ingredient (API).
Collapse
Affiliation(s)
- Pengxuan Xi
- Green Catalysis Center, College of Chemistry, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, China
| | - Wanxue Cao
- Green Catalysis Center, College of Chemistry, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, China
| | - Li Li
- Green Catalysis Center, College of Chemistry, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, China
| | - Weimin Shi
- Green Catalysis Center, College of Chemistry, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, China
| | - Fuxin Li
- Jiyuan Branch, Henan Tobacco Corporation, 38 Huanghe Road, Jiyuan, 459000, China
| | - Haitao Xu
- Zhengzhou Mingze Pharmaceutical Technology Co., Ltd., 369 Xisihuan Road, Zhengzhou, 450000, China
| | - Xiaojie Xu
- Zhengzhou Mingze Pharmaceutical Technology Co., Ltd., 369 Xisihuan Road, Zhengzhou, 450000, China
| | - Yu Ke
- School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, China
| | - Jianye Zhang
- Green Catalysis Center, College of Chemistry, Zhengzhou University, 100 Science Road, Zhengzhou, 450001, China
| |
Collapse
|
2
|
Paczkowska M, Mizera M, Dzitko J, Lewandowska K, Zalewski P, Cielecka-Piontek J. Vibrational (FT-IR, Raman) and DFT analysis on the structure of labile drugs. The case of crystalline tebipenem and its ester. J Mol Struct 2017. [DOI: 10.1016/j.molstruc.2016.12.074] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
3
|
Separation and Characterization of Process-Related Impurities and Forced Degradation Products of G004, a Novel Sulfonylurea Derivative. Chromatographia 2015. [DOI: 10.1007/s10337-015-2987-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
4
|
Talaczyńska A, Lewandowska K, Garbacki P, Zalewski P, Skibiński R, Miklaszewski A, Mizera M, Cielecka-Piontek J. Solid-state stability studies of crystal form of tebipenem. Drug Dev Ind Pharm 2015; 42:238-44. [DOI: 10.3109/03639045.2015.1044902] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- Alicja Talaczyńska
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland,
| | | | - Piotr Garbacki
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland,
| | - Przemysław Zalewski
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland,
| | - Robert Skibiński
- Department of Medicinal Chemistry, Medical University of Lublin, Lublin, Poland, and
| | - Andrzej Miklaszewski
- Institute of Materials Science and Engineering, Poznan University of Technology, Poznan, Poland
| | - Mikołaj Mizera
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland,
| | - Judyta Cielecka-Piontek
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland,
| |
Collapse
|
5
|
Cielecka-Piontek J, Paczkowska M, Zalewski P, Talaczyńska A, Mizera M. Tebipenem pivoxyl. Derivative spectroscopy study of stability of the first oral carbapenem. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2015; 135:14-19. [PMID: 25036644 DOI: 10.1016/j.saa.2014.06.083] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/04/2014] [Revised: 05/31/2014] [Accepted: 06/03/2014] [Indexed: 06/03/2023]
Abstract
A simple and selective derivative spectrophotometric method was developed for the quantitative determination of tebipenem and its pivoxyl ester in the presence of degradation products formed during degradation in aqueous solutions (hydrolysis, oxidation, phosphate buffer pH ∼6.0) and in the solid state (photolysis, thermolysis in dry air and at an increased relative air humidity). The method was based on zero-crossing first-derivative spectrophotometry (λ=341 nm for tebipenem pivoxyl and λ=320 nm for tebipenem), which eliminated the overlapping caused by various degradation products. The selectivity of the method for determination of tebipenem pivoxyl and tepipenem during stability studies was an effect of lack of substituents containing π-bond system chromophores in degradation products. It was also confirmed by comparison of the experimental spectra sample with the theoretical UV spectra and their first derivatives which were obtained by using the density functional theory with the B3LYP hybrid functional and 6-31G(d,p) basis set. The method were linear in the concentration range 16.70-220.0 μg mL(-1) for tebipenem (λ=320 nm; r=0.9989) and 10.70-160.0 μg mL(-1) for tebipenem pivoxyl (λ=341 nm, r=0.9990). The limits of detection and quantitation were 4.72 and 15.60 μg mL(-1) for tebipenem and 2.54 and 8.40 μg mL(-1) for tebipenem pivoxyl, respectively. The method had a good intra-day precision (RSD from 0.12% to 0.62%) and inter-day precision (RSD from 0.22% to 2.13%). The recovery of tebipenem and tebipenem pivoxyl ranged from 99.61% to 99.86% and from 99.38% to 99.87%, respectively. First-derivative spectrophotometry was used for a routine analysis of tebipenem and its ester as well as to monitor the conversion of tebipenem pivoxyl to tebipenem and to predict their degradation pathways.
Collapse
Affiliation(s)
- Judyta Cielecka-Piontek
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland.
| | - Magdalena Paczkowska
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
| | - Przemysław Zalewski
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
| | - Alicja Talaczyńska
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
| | - Mikołaj Mizera
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
| |
Collapse
|
6
|
Zalewski P, Talaczyńska A, Korban P, Garbacki P, Mizera M, Cielecka-Piontek J. An Approach to Transfer Methods from HPLC to UHPLC Techniques in Some Carbapenems. Chromatographia 2014; 77:1483-1487. [PMID: 25400287 PMCID: PMC4224748 DOI: 10.1007/s10337-014-2725-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2014] [Revised: 05/23/2014] [Accepted: 06/20/2014] [Indexed: 11/29/2022]
Abstract
Stability-indicating LC methods were developed and validated for the quantitative determination of doripenem, meropenem and tebipenem in the presence of their degradation products formed during forced degradation studies. Isocratic HPLC and UHPLC separations were performed with a core–shell Kinetex 1.7, 2.6 and 5 µm, all C18, 100A, 100 × 2.1 mm columns and the mobile phase composed of acetonitrile and 12 mmol L−1 ammonium acetate in different ratios. The flow rates of the mobile phase were: 0.5 mL min−1 for 1.7 µm column, and 1.0 mL min−1 for 2.6 and 5 µm ones. Detection wavelength was 298 nm and temperature was set at 30 °C. All analysed drugs were exposed to stress conditions which caused their hydrolysis and thermal degradation. The methods were validated by evaluation of linearity, accuracy, precision, selectivity and robustness. Proposed methods were successfully applied for the determination of investigated antibiotics during kinetic studies in aqueous solutions and in the solid state. The advantages of chromatographic procedures which are based on the use of C18 stationary phases with different particle sizes in the analysis of selected carbapenems were discussed.
Collapse
Affiliation(s)
- Przemysław Zalewski
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
| | - Alicja Talaczyńska
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
| | - Patrycja Korban
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
| | - Piotr Garbacki
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
| | - Mikołaj Mizera
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
| | - Judyta Cielecka-Piontek
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland
| |
Collapse
|
7
|
CIELECKA-PIONTEK JUDYTA, ZALEWSKI PRZEMYSŁAW, GARBACKI PIOTR, JURA EWELINA, TALACZYŃSKA ALICJA. Kinetics of Degradation of Biapenem. INT J CHEM KINET 2014. [DOI: 10.1002/kin.20860] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- JUDYTA CIELECKA-PIONTEK
- Department of Pharmaceutical Chemistry; Faculty of Pharmacy, Poznan University of Medical Sciences; Grunwaldzka 6 60-780 Poznań Poland
| | - PRZEMYSŁAW ZALEWSKI
- Department of Pharmaceutical Chemistry; Faculty of Pharmacy, Poznan University of Medical Sciences; Grunwaldzka 6 60-780 Poznań Poland
| | - PIOTR GARBACKI
- Department of Pharmaceutical Chemistry; Faculty of Pharmacy, Poznan University of Medical Sciences; Grunwaldzka 6 60-780 Poznań Poland
| | - EWELINA JURA
- Department of Pharmaceutical Chemistry; Faculty of Pharmacy, Poznan University of Medical Sciences; Grunwaldzka 6 60-780 Poznań Poland
| | - ALICJA TALACZYŃSKA
- Department of Pharmaceutical Chemistry; Faculty of Pharmacy, Poznan University of Medical Sciences; Grunwaldzka 6 60-780 Poznań Poland
| |
Collapse
|
8
|
Butler MS, Robertson AAB, Cooper MA. Natural product and natural product derived drugs in clinical trials. Nat Prod Rep 2014; 31:1612-61. [DOI: 10.1039/c4np00064a] [Citation(s) in RCA: 383] [Impact Index Per Article: 38.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The 25 Natural Product (NP)-derived drugs launched since 2008 and the 100 NP-derived compounds and 33 Antibody Drug Conjugates (ADCs) in clinical trials or in registration at the end of 2013 are reviewed.
Collapse
Affiliation(s)
- Mark S. Butler
- Division of Chemistry and Structural Biology
- Institute for Molecular Bioscience
- The University of Queensland
- Brisbane, Australia
| | - Avril A. B. Robertson
- Division of Chemistry and Structural Biology
- Institute for Molecular Bioscience
- The University of Queensland
- Brisbane, Australia
| | - Matthew A. Cooper
- Division of Chemistry and Structural Biology
- Institute for Molecular Bioscience
- The University of Queensland
- Brisbane, Australia
| |
Collapse
|